A French biotechnology firm announced progress in developing what would be the first vaccination ever for preventing dengue fever, the New York Times reports.
The company Sanofi on Monday said its developmental dengue vaccine cut infections by 56 percent in an initial advanced clinical test with 10,275 child participants in Southeast Asia. Additional information on the findings is slated for release in print and at a medical gathering later in 2014, the firm said.
Spread via mosquitos, the disease affects as many as 100 million people worldwide annually. There are concerns that it could also potentially be used in biological warfare.
The United States has committed biodefense dollars to preparing immunizations and other drug countermeasures against the virus, which most frequently kills younger people and often affects populations in the tropics and subtropics. The latest study took place in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Two-thirds of the trial subjects, all children from ages 2 to 14, received three shots of the vaccine. The remaining control group received a mock vaccination for the virus.
“This achievement is the result of more than 20 years of work in the field of dengue, collaborating with investigators, volunteers, authorities, scientific experts and international organizations,” Olivier Charmeil, head of the firm’s vaccination branch, said in released comments. “Our goal is to make dengue the next vaccine-preventable disease.”
What We're Following See More »
The US Fourth Circuit Court of Appeals on Friday overturned North Carolina's 2013 voter ID law, saying it was passed with “discriminatory intent." The decision sends the case back to the district judge who initially dismissed challenges to the law. "The ruling prohibits North Carolina from requiring photo identification from voters in future elections, including the November 2016 general election, restores a week of early voting and preregistration for 16- and 17-year-olds, and ensures that same-day registration and out-of-precinct voting will remain in effect."
An oil pipeline almost as long as the much-debated Keystone XL has won final approval to transport crude from North Dakota to Illinois, traveling through South Dakota and Iowa along the way. "The U.S. Army Corps of Engineers gave the final blessing to the Dakota Access pipeline on Tuesday. Developers now have the last set of permits they need to build through the small portion of federal land the line crosses, which includes major waterways like the Mississippi and the Missouri rivers. The so-called Bakken pipeline goes through mostly state and private land."
The U.S. economy grew at an anemic 1.2% in the second quarter, "well below the 2.6% growth economists surveyed by The Wall Street Journal had forecast." Consumer spending was "robust," but it was offset by "cautious" business investment. "Since the recession ended seven years ago, the expansion has failed to achieve the breakout growth seen in past recoveries. "The average annual growth rate during the current business cycle, 2.1%, remains the weakest of any expansion since at least 1949."
Sen. Chuck Schumer, the majority leader in waiting, not only thinks his party will take the Senate this fall, but that it's on the cusp of an era of "electoral dominance." He told Politico: “We’re going to have a Democratic generation. [President Barack Obama] helped create it. But it’s just where America’s moving demographically, ideologically and in every way. We’ll have a mandate to get something done.”
"Vice President Joe Biden will appear in an episode of Law & Order: Special Victims Unit that will mention the backlog of untested rape kits in many cities, as well as efforts to end violence against women—an issue close to Biden, who authored the Violence Against Women Act in 1994." He'll be in New York to tape the episode today.